Bausch Health Companies (BHC) Short Interest Ratio & Short Volume → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free BHC Stock Alerts $6.76 -0.31 (-4.38%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Bausch Health Companies Short Interest DataCurrent Short Volume20,510,000 sharesPrevious Short Volume20,710,000 sharesChange Vs. Previous Month-0.97%Dollar Volume Sold Short$179.67 millionShort Interest Ratio / Days to Cover6.7Last Record DateApril 30, 2024Outstanding Shares366,800,000 sharesFloat Size357,940,000 sharesShort Percent of Float5.73%Today's Trading Volume4,041,006 sharesAverage Trading Volume2,912,667 sharesToday's Volume Vs. Average139% Short Selling Bausch Health Companies ? Sign up to receive the latest short interest report for Bausch Health Companies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBHC Short Interest Over TimeBHC Days to Cover Over TimeBHC Percentage of Float Shorted Over Time Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Bausch Health Companies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202420,510,000 shares $179.67 million -1.0%5.7%6.7 $8.76 4/15/202420,710,000 shares $178.83 million -8.0%5.8%7.5 $8.64 3/31/202422,500,000 shares $238.73 million -5.4%6.3%8.5 $10.61 3/15/202423,780,000 shares $219.01 million -3.5%6.7%10.3 $9.21 2/29/202424,640,000 shares $231.25 million +14.4%6.9%10.5 $9.39 2/15/202421,530,000 shares $182.90 million +1.0%6.0%9.9 $8.50 Get the Latest News and Ratings for BHC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. 1/31/202421,310,000 shares $167.28 million -1.1%6.0%10.5 $7.85 1/15/202421,540,000 shares $183.74 million +2.1%6.0%9.6 $8.53 12/31/202321,100,000 shares $169.22 million -1.5%5.9%9.2 $8.02 12/15/202321,430,000 shares $156.01 million -3.1%6.0%9.6 $7.28 11/30/202322,120,000 shares $157.94 million +0.9%6.2%8.3 $7.14 11/15/202321,920,000 shares $152.23 million +2.3%6.1%7.7 $6.95 10/31/202321,420,000 shares $146.08 million +0.1%6.0%7.2 $6.82 10/15/202321,400,000 shares $152.80 million -5.2%6.0%7.3 $7.14 9/30/202322,580,000 shares $185.61 million -12.6%6.3%7.8 $8.22 9/15/202325,830,000 shares $219.94 million +4.6%7.3%9.1 $8.52 8/31/202324,700,000 shares $206.00 million +9.5%6.9%9.9 $8.34 8/15/202322,550,000 shares $187.50 million -1.7%6.3%8.1 $8.32 7/31/202322,940,000 shares $222.52 million -2.7%6.5%6.5 $9.70 7/15/202323,570,000 shares $198.70 million +4.2%6.6%6.6 $8.43 6/30/202322,630,000 shares $181.04 million -2.8%6.4%6.3 $8.00 6/15/202323,290,000 shares $173.16 million -2.4%6.6%6.5 $7.44 5/31/202323,860,000 shares $195.89 million +1.1%6.7%6.3 $8.21 5/15/202323,610,000 shares $142.37 million +1.1%6.7%5.4 $6.03 4/30/202323,350,000 shares $172.09 million -8.7%6.6%5.4 $7.37 4/15/202325,580,000 shares $191.59 million -2.0%7.2%5.7 $7.49 3/31/202326,110,000 shares $211.49 million -4.2%7.3%5.5 $8.10 3/15/202327,250,000 shares $207.92 million -0.8%7.7%5 $7.63 2/28/202327,480,000 shares $255.84 million +15.8%7.7%4.8 $9.31 2/15/202323,740,000 shares $213.19 million -1.1%6.7%3.9 $8.98 1/31/202324,000,000 shares $184.80 million -0.3%6.7%4.7 $7.70 1/15/202324,080,000 shares $180.60 million -9.5%6.8%4.6 $7.50 12/30/202226,620,000 shares $167.17 million -14.1%7.5%5.2 $6.28 12/15/202230,980,000 shares $239.48 million -2.6%8.7%5.8 $7.73 11/30/202231,800,000 shares $223.55 million +23.0%8.9%5.1 $7.03 11/15/202225,850,000 shares $185.60 million -4.9%7.2%3.8 $7.18 10/31/202227,190,000 shares $176.74 million -2.9%7.8%3.9 $6.50 10/15/202228,000,000 shares $180.60 million -6.1%8.0%3.2 $6.45 9/30/202229,830,000 shares $205.53 million +2.5%8.5%3.4 $6.89 9/15/202229,100,000 shares $222.32 million +35.8%8.3%3.3 $7.64I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look. BHC Short Interest - Frequently Asked Questions What is Bausch Health Companies' current short interest? Short interest is the volume of Bausch Health Companies shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 20,510,000 shares of BHC short. 5.73% of Bausch Health Companies' shares are currently sold short. Learn More on Bausch Health Companies' current short interest. What is a good short interest ratio for Bausch Health Companies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BHC shares currently have a short interest ratio of 7.0. Learn More on Bausch Health Companies's short interest ratio. Which institutional investors are shorting Bausch Health Companies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bausch Health Companies: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, SIG North Trading ULC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Simplex Trading LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bausch Health Companies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.73% of Bausch Health Companies' floating shares are currently sold short. Is Bausch Health Companies' short interest increasing or decreasing? Bausch Health Companies saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 20,510,000 shares, a drop of 1.0% from the previous total of 20,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bausch Health Companies' float size? Bausch Health Companies currently has issued a total of 366,800,000 shares. Some of Bausch Health Companies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bausch Health Companies currently has a public float of 357,940,000 shares. How does Bausch Health Companies' short interest compare to its competitors? 5.73% of Bausch Health Companies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bausch Health Companies: MoonLake Immunotherapeutics (14.00%), Merus (5.76%), Maravai LifeSciences Holdings, Inc. (6.66%), Janux Therapeutics, Inc. (9.55%), Rhythm Pharmaceuticals, Inc. (17.37%), Dyne Therapeutics, Inc. (18.91%), Amicus Therapeutics, Inc. (9.71%), Avidity Biosciences, Inc. (11.91%), ACADIA Pharmaceuticals Inc. (7.28%), MorphoSys AG (0.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bausch Health Companies stock? Short selling BHC is an investing strategy that aims to generate trading profit from Bausch Health Companies as its price is falling. BHC shares are trading down $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bausch Health Companies? A short squeeze for Bausch Health Companies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BHC, which in turn drives the price of the stock up even further. How often is Bausch Health Companies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BHC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MoonLake Immunotherapeutics Short Interest Merus Short Interest Maravai LifeSciences Short Interest Janux Therapeutics Short Interest Rhythm Pharmaceuticals Short Interest Dyne Therapeutics Short Interest Amicus Therapeutics Short Interest Avidity Biosciences Short Interest ACADIA Pharmaceuticals Short Interest MorphoSys Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BHC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap Profits